GT
RXL icon

Glenmede Trust’s ProShares Ultra Health Care RXL Stock Holding History

Glenmede Trust’s Portfolio RXL Stock Details RXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,000
Closed -$98K – 2505
2014
Q2 		$98K Hold
8,000
– – ﹤0.01% 1405
2014
Q1 		$90K Sell
8,000
-800
-9% -$8.83K ﹤0.01% 1460
2013
Q4 		$89K Buy
+8,800
New +$83.1K ﹤0.01% 1459

Other funds holding RXL

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
WSTAM
Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Glenmede Trust's RXL Position: Q3 2014 in Review

Glenmede Trust sold out of ProShares Ultra Health Care (RXL) in Q3 2014, closing a stake of 8,000 shares — an estimated $98K sold.

Glenmede Trust first reported a position in RXL in Q4 2013 and held it in 3 quarters. The position peaked at $98K in Q2 2014. 17 funds tracked by Wall St. Rank hold RXL as of Q3 2014.

  • Glenmede Trust reported no remaining ProShares Ultra Health Care position as of Q3 2014 after selling out during the quarter.
  • Glenmede Trust sold 8,000 ProShares Ultra Health Care shares in Q3 2014, an estimated $98K.
  • Glenmede Trust first reported a position in ProShares Ultra Health Care in Q4 2013 and held it in 3 quarters.
  • Glenmede Trust's ProShares Ultra Health Care position peaked at $98K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2014.

Based on Glenmede Trust's 13F filing for Q3 2014, filed 14 Nov 2014.